Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Epilepsy

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    February 2024
  1. RIVERA D, Santos D, Carmant L, Garcia HH, et al
    [Diagnosis of neurocysticercosis in patients with epilepsy living in the south-western Dominican Republic].
    Rev Neurol. 2024;78:109-116.
    PubMed     Abstract available


  2. IVAROLA P, Gonzalez B, Tedeschini I, Cordoba F, et al
    [Acute symptomatic epileptic seizures. A clinical-electroencephalographic etiological description and prognosis of an oncopediatric series].
    Rev Neurol. 2024;78:93-99.
    PubMed     Abstract available


  3. BELLIDO-CASTILLO E, Lopez-Sala A, Aparicio J, Cuadras D, et al
    Verbal episodic memory in children undergoing temporal lobe epilepsy surgery: a one-year follow-up study.
    Rev Neurol. 2024;78:61-71.
    PubMed     Abstract available


    January 2024
  4. RESENDIZ-APARICIO JC, Ruiz-Garcia M, Castro-Martinez E
    [A multicentre epilepsy registry in Mexico].
    Rev Neurol. 2024;78:9-15.
    PubMed     Abstract available


    December 2023
  5. PEREZ-NAVARRO VM, Canovas-Iniesta M, Palazon-Cabanes B, Navarro-Lozano M, et al
    [Epilepsy and inequality: demographic description and analysis of the difficulty in accessing advanced resources in a population in a small health area].
    Rev Neurol. 2023;77:259-265.
    PubMed     Abstract available


    November 2023
  6. HERNANDEZ-PRIETO A, Garrido-Martin M, Gomez-Martin H, Pablos-Lopez A, et al
    [Neonatal seizures and progression to epilepsy in a tertiary hospital].
    Rev Neurol. 2023;77:249-252.
    PubMed     Abstract available


  7. PUERTAS-PORRINO N, Fonseca-Hernandez E, Quintana-Luque M, Meler-Amella P, et al
    [EPICAP: educational intervention using instructional clips in patients with epilepsy. A randomised clinical trial].
    Rev Neurol. 2023;77:215-222.
    PubMed     Abstract available


    October 2023
  8. ORDONO-SAIZ MV, Pua-Torrejon RC, Justel-Rodriguez M, Arias-Vivas E, et al
    Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
    Rev Neurol. 2023;77:197-201.
    PubMed     Abstract available


    September 2023
  9. ORTIZ-ORTIGOSA A, Calvo-Medina R, Ruiz-Garcia C, Vera-Medialdea R, et al
    [KIF1A gene-associated neurological disease: the correlation between genotype and phenotype].
    Rev Neurol. 2023;77:141-145.
    PubMed     Abstract available


    August 2023
  10. FERNANDEZ-CABRERA A, Lopez-Gonzalez FJ, Garcia-de Soto J, Pardellas-Santiago E, et al
    [The sign of the cross: a very rare automatism in temporal lobe epilepsy. Two case reports].
    Rev Neurol. 2023;77:105-108.
    PubMed     Abstract available


  11. TREJO-GABRIEL-GALAN JM, Cubo-Delgado E
    [Telephone assistance for neurological diseases: a systematic review].
    Rev Neurol. 2023;77:67-73.
    PubMed     Abstract available


    July 2023
  12. ORTIZ-DE LA ROSA JS, Ramon-Gomez JL, Martinez-Cordoba N, Lince-Rivera I, et al
    SARS-CoV-2 vaccination in paediatric patients with epilepsy: experience of a tertiary center in Colombia.
    Rev Neurol. 2023;77:13-18.
    PubMed     Abstract available


    June 2023
  13. VILLAGRAN-SANCHO D, Luque-Ambrosiani AC, Mayorga-Moron C, Gomez-Fernandez FJ, et al
    [Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report].
    Rev Neurol. 2023;76:399-402.
    PubMed     Abstract available


    May 2023
  14. PLANS-GALVAN O, Daniel X, Rosich S, Blazquez-Alcaide V, et al
    [Use of isoflurane as treatment for super-refractory status epilepticus].
    Rev Neurol. 2023;76:309-312.
    PubMed     Abstract available


    April 2023
  15. MORENO-MAYORGA B, Velez-Botero H, Fandino-Franky J, Perez-Almanza N, et al
    [Quality of life in people with epilepsy: beyond seizures].
    Rev Neurol. 2023;76:257-264.
    PubMed     Abstract available


  16. LORENZO-RUIZ M, Novo-Ponte S, Iglesias-Escalera G, Cazorla-Calleja R, et al
    [Angelman syndrome in adulthood].
    Rev Neurol. 2023;76:217-226.
    PubMed     Abstract available


    March 2023
  17. SOUSA E, Pinto M, Ferreira M, Monteiro C, et al
    Neurocognitive and psychological comorbidities in patients with self-limited centrotemporal spike epilepsy. A case-control study.
    Rev Neurol. 2023;76:153-158.
    PubMed     Abstract available


    February 2023
  18. PAREDES-ARAGON E, Ruiz-Garcia R, Burneo JG
    [Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies].
    Rev Neurol. 2023;76:137-146.
    PubMed     Abstract available


  19. SALINAS-SALVADOR B, Moreno-Sanchez A, Carmen-Marcen G, Molina-Hernanz D, et al
    ['Wait and see' in paediatric epilepsy. Our experience].
    Rev Neurol. 2023;76:83-89.
    PubMed     Abstract available


    January 2023
  20. DA SILVA CARDOSO J, Curto C, Manuel-Vieira P, Ashworth J, et al
    Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population.
    Rev Neurol. 2023;76:9-14.
    PubMed     Abstract available


    December 2022
  21. PASTOR J, Vega-Zelaya L, Torres CV, Navas-Garcia M, et al
    [Towards a positive physiological definition of the deep brain nuclei in humans].
    Rev Neurol. 2022;75:369-376.
    PubMed     Abstract available


  22. LOPEZ-ANGUITA S, Gutierrez-Ruano B, Munoz-Gonzalez A, Valenzuela-Rojas FJ, et al
    [Epilepsy in cancer patients: primary prevention and the importance of high-risk patient screening].
    Rev Neurol. 2022;75:349-356.
    PubMed     Abstract available


    November 2022
  23. JUIZ-FERNANDEZ A, Chavarria-Miranda A, Prieto-Gonzalez A, Rodriguez-Osorio X, et al
    [No fear of anything: epilepsy, psychiatric comorbidity and surgery. A clinical case report].
    Rev Neurol. 2022;75:319-321.
    PubMed     Abstract available


  24. SERRANO-TABARES C, Trujillo-Gomez J, Morales-Gil RM, Aguilar-Perez Y, et al
    Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.
    Rev Neurol. 2022;75:305-310.
    PubMed     Abstract available


  25. NAVA-CEDENO DJ, Alonso-Cerezo MC, Sanz-Garcia A, Vega-Zelaya L, et al
    [Association between single nucleotide genetic polymorphisms in ABC transporter genes with drug-resistant epilepsy in the Spanish population].
    Rev Neurol. 2022;75:251-259.
    PubMed     Abstract available


    October 2022
  26. SOTO-INSUGA V, Gonzalez-Alguacil E, Garcia-Penas JJ
    [Paediatric status epilepticus].
    Rev Neurol. 2022;75:225-238.
    PubMed     Abstract available


    September 2022
  27. RUBIO-NAZABAL E, Alvarez-Perez P, Cores-Bartolome C, Lema-Facal T, et al
    [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
    Rev Neurol. 2022;75:159-163.
    PubMed     Abstract available


    July 2022
  28. SANCHEZ-ZAPATA P, Zapata-Berruecos JF, Pelaez-Sanchez RG
    [Structural changes to the brain in drug-resistant juvenile myoclonic epilepsy].
    Rev Neurol. 2022;75:23-30.
    PubMed     Abstract available


  29. ARTEAGA-RODRIGUEZ C, Menine-Kubis M, Teixeira-Arteaga CB, Hernandez-Fustes OJ, et al
    Clinical characteristics of patients with epilepsy attending primary health care.
    Rev Neurol. 2022;75:7-12.
    PubMed     Abstract available


    June 2022
  30. ANAYA-GONZALEZ JL, Lopez-Munoz F, Carmona-Alvarez Builla E, Miniet-Castillo AE, et al
    [Correlation between clinical and tomographic variables in patients with neurocysticercosis. A study in a cohort of patients in Sierra Norte, Ecuador, between 2019 and 2020].
    Rev Neurol. 2022;74:383-391.
    PubMed     Abstract available


    May 2022
  31. MOSCOL G, Espino PH, Mayor LC, Burneo JG, et al
    [Epilepsy with catamenial pattern].
    Rev Neurol. 2022;74:303-311.
    PubMed     Abstract available


    April 2022
  32. CATALAN-AGUILAR J, Lozano-Garcia A, Gonzalez-Bono E, Villanueva V, et al
    Academic and employment insertion as a factor related to quality of life in patients with drug-resistant temporal lobe epilepsy.
    Rev Neurol. 2022;74:219-227.
    PubMed     Abstract available


    March 2022
  33. NOGUEIRA M, Melo C, Grangeia A, Magalhaes T, et al
    PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Rev Neurol. 2022;74:170-173.
    PubMed     Abstract available


    December 2021
  34. TOLEDANO R, Gil-Nagel A
    [Treatment of epilepsy with perampanel: conversion from add-on therapy to monotherapy].
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  35. SANABRIA-SANCHINEL AA, Escobar-Pineda ES, Oliveros I, Perdomo-Mendizabal AL, et al
    [Telemedicine and epilepsy: healthcare experience of a national reference center during the COVID-19 pandemic].
    Rev Neurol. 2021;73:390-393.
    PubMed     Abstract available


    October 2021
  36. CANO-LOPEZ I, Vazquez-Costa JF, Gutierrez A, Villanueva V, et al
    [Cognitive reserve as a modulating factor in the impact of surgery on visual memory and naming in temporal lobe epilepsy patients].
    Rev Neurol. 2021;73:267-274.
    PubMed     Abstract available


  37. FERNANDEZ-ALONSO C, Gonzalez-Martinez F, Alonso-Aviles R, Linan-Lopez M, et al
    [On the treatment of epileptic seizures in patients with epilepsy in hospital emergency departments].
    Rev Neurol. 2021;73:258-259.
    PubMed    


  38. NAVARRO-PEREZ MP, Viloria-Alebesque A

    Rev Neurol. 2021;73:259-260.
    PubMed    


    September 2021
  39. GARCIA-PENAS JJ, Gil Nagel-Rein A, Sanchez-Carpintero R, Villanueva-Haba V, et al
    Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  40. CANTARIN-EXTREMERA V, Bernardino-Cuesta B, Martin-Villaescusa C, Melero-Llorente J, et al
    [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
    Rev Neurol. 2021;73:141-150.
    PubMed     Abstract available


    July 2021
  41. MARTINEZ-PIAS E, Castineira-Mourenza JA, Prieto-Gonzalez AJ, Rodriguez-Osorio X, et al
    [Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
    Rev Neurol. 2021;73:77-79.
    PubMed     Abstract available


  42. CARDENAL-MUNOZ E, Nabbout R, Boronat S, Lara-Herguedas J, et al
    Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown.
    Rev Neurol. 2021;73:57-65.
    PubMed     Abstract available


    June 2021
  43. NAVARRO-PEREZ MP, Viloria-Alebesque A, Garces-Anton E, Marin-Gracia M, et al
    [Emergency department management of epileptic seizures in patients with epilepsy].
    Rev Neurol. 2021;72:419-425.
    PubMed     Abstract available


    April 2021
  44. VILLANUEVA V, Carreno-Martinez M, Gil Nagel-Rein A, Lopez-Gonzalez FJ, et al
    New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Rev Neurol. 2021;72.
    PubMed     Abstract available


  45. HERNANDEZ-RUBIO L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Saez A, et al
    [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
    Rev Neurol. 2021;72:263-268.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.